Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Sell
11,450
-95
-0.8% -$4.18K ﹤0.01% 3664
2025
Q4
$566K Buy
11,545
+1,020
+10% +$42.8K ﹤0.01% 3576
2025
Q3
$507K Buy
+10,525
New +$397K ﹤0.01% 3619
2024
Q2
Sell
-57,750
Closed -$764K 3902
2024
Q1
$764K Sell
57,750
-1,277
-2% -$13.6K ﹤0.01% 3280
2023
Q4
$661K Sell
59,027
-7,228
-11% -$85.5K ﹤0.01% 3351
2023
Q3
$952K Sell
66,255
-590
-0.9% -$10.3K ﹤0.01% 3165
2023
Q2
$1.27M Sell
66,845
-30,944
-32% -$681K ﹤0.01% 3075
2023
Q1
$2.07M Sell
97,789
-25,509
-21% -$435K ﹤0.01% 2831
2022
Q4
$1.82M Sell
123,298
-1,446
-1% -$17.3K ﹤0.01% 2853
2022
Q3
$1.51M Buy
124,744
+19,406
+18% +$157K ﹤0.01% 2910
2022
Q2
$767K Buy
+105,338
New +$711K ﹤0.01% 3226

Other funds holding HROW

Ameriprise's HROW Position: Q1 2026 in Review

Ameriprise reduced its Harrow (HROW) stake by 0.82% in Q1 2026, selling an estimated $4.18K and leaving 11,450 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Ameriprise first reported a position in HROW in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.07M in Q1 2023. 218 funds tracked by Wall St. Rank hold HROW as of Q1 2026.

  • Ameriprise held 11,450 shares of Harrow worth $404K as of Q1 2026.
  • Ameriprise sold 95 Harrow shares in Q1 2026, an estimated $4.18K.
  • Harrow made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3664 holding.
  • Ameriprise first reported a position in Harrow in Q2 2022 and has held it in 11 quarters since.
  • Ameriprise's Harrow position peaked at $2.07M in Q1 2023.
  • 218 funds tracked by Wall St. Rank held Harrow as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.